173 related articles for article (PubMed ID: 25407578)
1. Psychopharmacology and the future of personalized treatment.
Nemeroff CB
Depress Anxiety; 2014 Nov; 31(11):906-8. PubMed ID: 25407578
[No Abstract] [Full Text] [Related]
2. Neuroimaging and the future of personalized treatment in psychiatry.
Etkin A
Depress Anxiety; 2014 Nov; 31(11):899-901. PubMed ID: 25407576
[No Abstract] [Full Text] [Related]
3. Personalized medicine in psychiatry: new technologies and approaches.
Costa e Silva JA
Metabolism; 2013 Jan; 62 Suppl 1():S40-4. PubMed ID: 23018148
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine for patients with asthma.
Greenberger PA
J Allergy Clin Immunol; 2010 Feb; 125(2):305-6. PubMed ID: 20159238
[No Abstract] [Full Text] [Related]
5. Personalized medicine, pharmacogenomics, and the practice of psychiatry: on the threshold of predictive therapeutics in psychopharmacology?
Stahl SM
CNS Spectr; 2008 Feb; 13(2):115-8. PubMed ID: 18227742
[No Abstract] [Full Text] [Related]
6. Drugs, diabetes and pharmacogenomics: the road to personalized therapy.
Watanabe RM
Pharmacogenomics; 2011 May; 12(5):699-701. PubMed ID: 21619432
[No Abstract] [Full Text] [Related]
7. Where are we today with personalized medicine?
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Nov; 50(11):11-3. PubMed ID: 23066831
[TBL] [Abstract][Full Text] [Related]
8. Personalized oxycodone dosing: using pharmacogenetic testing and clinical pharmacokinetics to reduce toxicity risk and increase effectiveness.
Fudin J; Atkinson TJ
Pain Med; 2014 May; 15(5):723-5. PubMed ID: 24636013
[No Abstract] [Full Text] [Related]
9. A piece in the puzzle of personalized medicine.
Kroemer HK; Meyer zu Schwabedissen HE
Clin Pharmacol Ther; 2010 Jan; 87(1):19-20. PubMed ID: 20019696
[TBL] [Abstract][Full Text] [Related]
10. Achieving the promise of personalized medicine.
Reynolds KS
Clin Pharmacol Ther; 2012 Oct; 92(4):401-5. PubMed ID: 22992663
[TBL] [Abstract][Full Text] [Related]
11. Future paths in psychopharmacology
.
Thibaut F
Dialogues Clin Neurosci; 2019; 21(2):115-116. PubMed ID: 31636485
[TBL] [Abstract][Full Text] [Related]
12. Psychopharmacogenetics and psychiatric genetics: similar methodological challenges.
Maziade M; Roy MA; Mérette C; Bissonnette L; Quirion R; Palmour R
J Psychiatry Neurosci; 1999 May; 24(3):211-4. PubMed ID: 10354654
[No Abstract] [Full Text] [Related]
13. Cancer drugs find a companion with new diagnostic tests.
Schubert C
Nat Med; 2011 Oct; 17(10):1157. PubMed ID: 21988963
[No Abstract] [Full Text] [Related]
14. The 21st annual meeting of the Canadian College of Neuropsychopharmacology. Montreal, Canada, June 14-17, 1998.
Srivastava LK; Rochford J; Young SN
J Psychiatry Neurosci; 1998 Nov; 23(5):277-87. PubMed ID: 9846032
[No Abstract] [Full Text] [Related]
15. Psychiatric pharmacogenetics: a developing science.
Berrettini W
Neuropsychopharmacology; 2002 Jan; 26(1):128-9. PubMed ID: 11751039
[No Abstract] [Full Text] [Related]
16. Personalised treatment of arthritis in the next eRA.
Tas SW
Neth J Med; 2009 Dec; 67(11):362-3. PubMed ID: 20009111
[No Abstract] [Full Text] [Related]
17. One size fits one: pharmacogenetics in gastroenterology.
Porayette P; Flockhart D; Gupta SK
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):565-70. PubMed ID: 24486737
[TBL] [Abstract][Full Text] [Related]
18. Toward personalized medicine in the neuropsychiatric field.
Wong EH; Fox JC; Ng MY; Lee CM
Int Rev Neurobiol; 2011; 101():329-49. PubMed ID: 22050858
[TBL] [Abstract][Full Text] [Related]
19. Clinical psychopharmacology: advances and challenges from 1965 to 2006.
Crismon ML
Ann Pharmacother; 2006 Sep; 40(9):1649-50. PubMed ID: 16896024
[No Abstract] [Full Text] [Related]
20. Proteomic advances hold promise for precision medicine.
Smith AD
Am J Manag Care; 2014 Mar; 20(5 Spec No.):E14. PubMed ID: 25618628
[No Abstract] [Full Text] [Related]
[Next] [New Search]
